What is Scotiabank’s Estimate for Albemarle FY2026 Earnings?

Albemarle Corporation (NYSE:ALB) – Research analysts at Scotiabank raised their FY2026 EPS estimates for Albemarle in a note issued to investors on Monday, November 10th. Scotiabank analyst B. Isaacson now forecasts that the specialty chemicals company will post earnings of $1.92 per share for the year, up from their prior forecast of $1.24. Scotiabank currently has a “Sector Perform” rating and a $85.00 target price on the stock. The consensus estimate for Albemarle’s current full-year earnings is ($0.04) per share.

Albemarle (NYSE:ALB) last issued its quarterly earnings results on Wednesday, November 5th. The specialty chemicals company reported ($0.19) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.92) by $0.73. The company had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.27 billion. Albemarle had a negative return on equity of 1.87% and a negative net margin of 18.61%.The business’s revenue for the quarter was down 3.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($1.55) EPS.

Several other equities research analysts have also commented on the company. Cowen restated a “hold” rating on shares of Albemarle in a research note on Thursday, October 9th. Zacks Research downgraded shares of Albemarle from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 5th. Wall Street Zen raised shares of Albemarle from a “sell” rating to a “hold” rating in a research note on Saturday, August 16th. UBS Group raised their price objective on Albemarle from $85.00 to $107.00 and gave the company a “neutral” rating in a research report on Thursday. Finally, Argus upped their target price on Albemarle from $90.00 to $120.00 in a research report on Tuesday, October 14th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, sixteen have given a Hold rating and five have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Albemarle presently has a consensus rating of “Hold” and an average target price of $99.38.

Albemarle Trading Up 5.6%

NYSE:ALB traded up $6.22 during mid-day trading on Thursday, reaching $116.54. The company’s stock had a trading volume of 3,917,910 shares, compared to its average volume of 3,570,256. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.31 and a quick ratio of 1.47. The stock has a market cap of $13.72 billion, a P/E ratio of -12.52 and a beta of 1.70. The company’s fifty day simple moving average is $89.57 and its two-hundred day simple moving average is $75.37. Albemarle has a twelve month low of $49.43 and a twelve month high of $119.28.

Institutional Trading of Albemarle

Several institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its position in shares of Albemarle by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 14,672,272 shares of the specialty chemicals company’s stock valued at $1,056,697,000 after buying an additional 77,773 shares during the last quarter. Geode Capital Management LLC boosted its position in Albemarle by 2.0% during the 2nd quarter. Geode Capital Management LLC now owns 2,954,331 shares of the specialty chemicals company’s stock valued at $184,782,000 after purchasing an additional 59,104 shares during the period. ProShare Advisors LLC grew its stake in Albemarle by 48.5% during the 2nd quarter. ProShare Advisors LLC now owns 2,870,110 shares of the specialty chemicals company’s stock worth $179,870,000 after buying an additional 937,538 shares during the last quarter. Manning & Napier Advisors LLC acquired a new stake in Albemarle in the third quarter worth $138,723,000. Finally, Dimensional Fund Advisors LP lifted its stake in Albemarle by 28.7% in the first quarter. Dimensional Fund Advisors LP now owns 1,538,706 shares of the specialty chemicals company’s stock valued at $110,814,000 after buying an additional 343,210 shares during the last quarter. Institutional investors own 92.87% of the company’s stock.

Albemarle Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Friday, December 12th will be issued a dividend of $0.405 per share. This represents a $1.62 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend is Friday, December 12th. Albemarle’s dividend payout ratio (DPR) is currently -101.89%.

About Albemarle

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.